| Literature DB >> 21846096 |
Nathalie Busschaert1, Marco Wenzel, Mark E Light, Paulina Iglesias-Hernández, Ricardo Pérez-Tomás, Philip A Gale.
Abstract
A series of easy-to-make fluorinated tripodal anion transporters containingEntities:
Mesh:
Substances:
Year: 2011 PMID: 21846096 PMCID: PMC3436094 DOI: 10.1021/ja205884y
Source DB: PubMed Journal: J Am Chem Soc ISSN: 0002-7863 Impact factor: 15.419
Chart 1Structures of Ureas 1–5 and Thioureas 6–10
Association Constants Ka (M–1) for the Binding of Compounds 1–10 to Various Anions in DMSO-d6 Containing 0.5% Water at 298 K, Following the Most Upfield (Thio)urea NH (errors are within 15%).a
| Cl– | SO42– | H2PO4– | HCO3– | NO3– | |
|---|---|---|---|---|---|
| Urea-Based Compounds | |||||
| 882 | >104 | 443 | – | – | |
| 575 | >104 | 452 | 365 | – | |
| 166 | >104 | >104 | >104 | – | |
| 405 | >104 | 243 | 156 | – | |
| 517 | >104 | – | – | – | |
| Thiourea-Based Compounds | |||||
| 191 | >104 | 256 | – | – | |
| 179 | >104 | 227 | – | – | |
| 128 | >104 | 130 | – | – | |
| 156 | – | – | – | – | |
| – | – | – | – | – | |
Anions added as TBA salts, except HCO3– which was added as a TEA salt. Fitted to 1:1 model.
Previously published data.[17]
Data for DMSO-d6/10% water, data for DMSO-d6/0.5% water could not be fitted.
Data could not be fitted to any model.
No significant shift of NH peaks, no binding.
Data for neat DMSO-d6 by Ghosh et al.,[19] values for DMSO-d6/0.5% water are expected to be lower.
2:1 model.
New peaks due to deprotonation of bound H2PO4– and subsequent binding of HPO42–.
Peak broadening.
Figure 1(a) 1H NMR titration with compound 5 in DMSO-d6/0.5% water with tetrabutylammonium dihydrogen phosphate; (i) free receptor; (ii) one equivalent of tetrabutylammonium dihydrogen phosphate; (iii) 2 equivalents of tetrabutylammonium dihydrogen phosphate; (iv) 3 equivalents of tetrabutylammonium dihydrogen phosphate. (b) 1H NMR titration with compound 5 in DMSO-d6/0.5% water with tetrabutylammonium dihydrogen phosphate and TBA hydroxide; (i) free receptor; (ii) one equivalent of tetrabutylammonium dihydrogen phosphate; (iii) one equivalent of tetrabutylammonium dihydrogen phosphate + one equivalent of tetrabutylammonium OH; (iv) one equivalent of tetrabutylammonium dihydrogen phosphate +1.5 equiv of tetrabutylammonium OH.
Figure 2X-ray crystal structures of 5, 7, and 8 with a variety of anionic guests. Ligands are represented as wireframes, and bound anions are shown in a spacefilling view (0.6 times van der Waals radius). Solvent molecules, counterions, and noninteracting hydrogens are omitted for clarity: C (gray), H (white), N (blue), S (yellow), O (red), F (green), Cl (dark green), P (orange). Hydrogen bonds are represented by dashed lines. (a) Free ligand 7; (b) 7⊃Cl; (c) (7)2⊃SO4 (disordered sulfate); (d) 8⊃SO4·TBA; (e) (5)2⊃CO3; (f) (8-H)2; (g) (7)2⊃HPO4 (disordered hydrogen phosphate); (h) (8⊃NO3)2.
Figure 3Spacefilling representations of the X-ray structures of (a) 2⊃Cl and (b) (5)2⊃CO3. Ligands are shown in grayscale and anions in color: C (gray), O (red), Cl (green).
Figure 4Chloride efflux promoted by 1–10 (2% molar carrier to lipid) from unilamellar POPC vesicles loaded with 489 mM NaCl buffered to pH 7.2 with 5 mM sodium phosphate salts. The vesicles were dispersed in 489 mM NaNO3 buffered to pH 7.2 with 5 mM sodium phosphate salts. At the end of the experiment, detergent was added to lyse the vesicles and calibrate the ISE to 100% chloride efflux. Each point represents the average of three trials. DMSO was used as control. (a) Urea compounds 1–5. (b) Thiourea compounds 6–10.
Figure 5Chloride efflux promoted by 1–10 (2% molar carrier to lipid) from unilamellar POPC vesicles loaded with 450 mM NaCl buffered to pH 7.2 with 20 mM sodium phosphate salts. The vesicles were dispersed in 162 mM Na2SO4 buffered to pH 7.2 with 20 mM sodium phosphate salts. At t = 120 s, a solution of NaHCO3 was added to give a 40 mM external concentration. At the end of the experiment, detergent was added to lyse the vesicles and calibrate the ISE to 100% chloride efflux. Each point represents the average of three trials. DMSO was used as control. (a) Urea compounds 1–5. (b) Thiourea compounds 6–10.
Figure 6Evidence for transmembrane transport of sulfate. Unilamellar POPC vesicles were loaded with 100 mM NaCl and 2 mM lucigenin buffered to pH 7.2 with 20 mM sodium phosphate salts and dispersed in a 100 mM NaCl solution (buffered to pH 7.2). At t = 30 s, a solution of the appropriate anion was added (final concentration of 40 mM NaNO3 (red), 40 mM Na2SO4 (green) or 40 mM NaCl (blue)). At t = 60 s, a methanol solution of the putative transporter was added (2% molar carrier to lipid). At the end of the experiment (240 s), detergent was added to lyse the vesicles. Each point represents the average of three trials. A blank experiment was performed by addition of Na2SO4, followed by addition of methanol; (a) compound 8. (b) compound 3.
Overview of Transport Assays and Lipophilicity of Compounds 1–10
| compound | clog | EC50, 270s | EC50, 270s | ||||
|---|---|---|---|---|---|---|---|
| Urea-Based Compounds | |||||||
| 2.06 | 0.081 | 5.6 | 1.2 | 0.024 | >5 | – | |
| 2.53 | 0.571 | 0.43 | 1.4 | 0.081 | >5 | – | |
| 4.43 | 1.84 | 0.24 | 1.4 | 0.250 | – | – | |
| 4.82 | 1.35 | 0.052 | 1.1 | 0.46 | 0.24 | 1.2 | |
| 7.59 | 1.01 | 0.0044 | 1.6 | 0.77 | 0.036 | 1.5 | |
| Thiourea-Based Compounds | |||||||
| 5.50 | 0.97 | 0.31 | 1.9 | 0.186 | 2.3 | 1.0 | |
| 5.97 | 3.3 | 0.042 | 2.9 | 0.47 | 0.35 | 1.2 | |
| 7.87 | 3.2 | 0.032 | 2.4 | 0.38 | – | – | |
| 8.26 | 1.18 | 0.077 | 4.8 | 0.47 | 0.11 | 4.8 | |
| 11.03 | 0.90 | 0.042 | 5.0 | 0.76 | 0.14 | 3.8 | |
clog P calculated using Spartan ’08 for Macintosh (Ghose–Crippen model).
Initial rate of chloride efflux for 2% molar carrier to lipid (% s–1).
EC50, 270s defined as concentration (mol % carrier to lipid) needed to obtain 50% efflux after 270 s.
Hill coefficient.
Initial rate of chloride efflux (after addition of NaHCO3) for 2% carrier to lipid (% s–1).
Accurate Hill analysis could not be performed due to low activity.
Meaningful Hill analysis could not be performed due to significant background transport in the absence of NaHCO3 (HCl symport and/or Cl–/SO42– antiport).
Figure 7Chloride efflux promoted by various concentrations of 5 from unilamellar POPC vesicles loaded with 489 mM NaCl buffered to pH 7.2 with 5 mM sodium phosphate salts and dispersed in 489 mM NaNO3 buffered to pH 7.2 with 5 mM sodium phosphate salts. At the end of the experiment, detergent was added to lyse the vesicles and calibrate the ISE to 100% chloride efflux. Each point represents the average of three trials. DMSO was used as control. Carrier to lipid ratios of 1:50, 1:10000, 1:33000, 1:100000, and 1:250000 were used.
Figure 8Single-point screening of receptors 1–10 (10 μM) tested on a collection of different cancer cell lines, from left to right, GLC4, HT29, DLD1, HN4, CAL27, and SW620; (a) 24-h cell viability of cell exposure to ureas 1–5; (b) 24-h cell viability of cell exposure to thioureas 6–10.
IC50 Values of Receptors 4, 5, 8, 9, and 10 Obtained from MTT Assays on GLC4, HN4 and CAL27 Cell Lines at 24 h Exposure Timea
| receptors | GLC4 | CAL27 | HN4 |
|---|---|---|---|
| 7.18 ± 0.91 | 25.77 ± 8.31 | 27.63 ± 3.35 | |
| 5.12 ± 0.98 | 10.93 ± 1.88 | 14.73 ± 0.81 | |
| 2.43 ± 0.14 | 12.16 ± 1.61 | 11.04 ± 0.04 | |
| 2.70 ± 0.04 | 10.98 ± 0.80 | 8.71 ± 0.79 | |
| 3.05 ± 0.06 | 10.76 ± 0.82 | 9.05 ± 0.52 |
Results represent a mean of three independent experiments with standard deviation and are in μM.
Figure 9Acridine orange staining of GLC4 cell line after exposure of 1 h to different receptors: (a) untreated cells (control), (b) cells treated with receptor 2, (c) cells treated with receptor 3, (d) cells treated with receptor 7, (e) cells treated with receptor 8, (f) cells treated with receptor 9. (a–c) Cells with granular orange fluorescence in the cytoplasm; (d–f) cells with complete disappearance of orange fluorescence cytoplasm granules.
Figure 10Hoechst 33342 staining of GLC4 cell line after exposure to different receptors for 24 h: (a) untreated cells (control), (b) cells treated with receptor 2, (c) cells treated with receptor 4, (d) cells treated with receptor 7, (e) cells treated with receptor 8, (f) cells treated with receptor 9. (a–c) Cells with normal nuclear morphology; (d–f) cells with condensation of the nuclei and nuclei with “bean shape”.